ArticleActa bio-medica : Atenei Parmensis2022

The The use of oral glucose-lowering agents (GLAs) in β-thalassemia patients with diabetes: Preliminary data from a retrospective study of ICET-A Network.

Vincenzo De Sanctis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.